Procter & Gamble (PG)
(Delayed Data from NYSE)
$167.06 USD
-1.41 (-0.84%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $167.10 +0.04 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$167.06 USD
-1.41 (-0.84%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $167.10 +0.04 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Zacks News
Core PCE Inflation Drops to 2 - Year Low
by Zacks Equity Research
Core PCE Inflation Drops to 2 - Year Low
Here's What Key Metrics Tell Us About P&G (PG) Q4 Earnings
by Zacks Equity Research
Although the revenue and EPS for P&G (PG) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Procter & Gamble (PG) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 3.79% and 2.66%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Procter & Gamble (PG) Ahead of Earnings?
by Zacks Equity Research
Procter & Gamble (PG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here's Why Procter & Gamble (PG) is Poised for Q4 Earnings Beat
by Zacks Equity Research
Procter & Gamble's (PG) unwavering commitment to leverage its brand strength and adopt effective strategies has been bolstering its organic sales and market position.
Investors Increasingly Betting on Soft Landing but the Fed Will Throw Cold Water
by Mayur Thaker
If the Fed continues to hike despite softening inflation and economic fundamentals, recession odds increase.
The Zacks Analyst Blog Highlights Alphabet, Procter & Gamble, Linde, Comcast and Elevance Health
by Zacks Equity Research
Alphabet, Procter & Gamble, Linde, Comcast and Elevance Health are included in this Analyst Blog.
Top Analyst Reports for Alphabet, Procter & Gamble & Linde
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), The Procter & Gamble Company (PG) and Linde plc (LIN).
Procter & Gamble (PG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
P&G (PG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Coca-Cola (KO) Set to Beat Q2 Earnings: What Should You Know?
by Zacks Equity Research
Coca-Cola's (KO) Q2 results to reflect benefits from share gains in the at-home and away-from-home channels, and continued growth in the price/mix.
Factors to Decide Keurig Dr Pepper's (KDP) Fate in Q2 Earnings
by Zacks Equity Research
Keurig Dr Pepper's (KDP) Q2 results are expected to reflect headwinds related to input cost inflation, rising transportation costs and supply-chain disruptions.
Procter & Gamble (PG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $150.56 in the latest trading session, marking a +0.18% move from the prior day.
Why P&G (PG) Could Beat Earnings Estimates Again
by Zacks Equity Research
P&G (PG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $148.99 in the latest trading session, marking a -0.71% move from the prior day.
Procter & Gamble (PG) Widens Spectrum on Value Creation
by Zacks Equity Research
Procter & Gamble (PG) advances the execution of the integrated strategies -- Supply Chain initiatives and digital penetration to strengthen the organization.
Zacks Value Investor Highlights: Coca-Cola, American Express, Moody's, Procter & Gamble and Amazon.com
by Zacks Equity Research
Coca-Cola, American Express, Moody's, Procter & Gamble and Amazon.com have been highlighted in this Value Investor article.
Should You Hold a Stock for Forever?
by Tracey Ryniec
Lessons from Berkshire Hathaway's portfolio on holding stocks for decades.
Should You Invest in the iShares U.S. Consumer Staples ETF (IYK)?
by Zacks Equity Research
Sector ETF report for IYK
Molson Coors (TAP) Rallies 25.1% in 1H23: Things to Note
by Zacks Equity Research
Molson Coors (TAP) remains well placed on the back of brand strength, product innovation and a revitalization plan.
Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $148.08, moving -0.52% from the previous trading session.
Should You Invest in the Vanguard Consumer Staples ETF (VDC)?
by Zacks Equity Research
Sector ETF report for VDC
Is Fidelity High Dividend ETF (FDVV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FDVV
Why You Must Consider Colgate (CL) Stock Before Q2 Earnings
by Zacks Equity Research
Colgate (CL) is well-poised on its innovation efforts, pricing actions, digital capabilities and progress on revenue growth management initiatives.
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Zacks Equity Research
Sector ETF report for FSTA
Constellation Brands (STZ) Q1 Earnings & Sales Top Estimates
by Zacks Equity Research
Constellation Brands' (STZ) Q1 results reflect strength in its beer business and cost-efficiency initiatives. As a result, it retains the fiscal 2024 view.